Literature DB >> 19833419

Paraneoplastic syndromes in patients with primary oral cancers: a systematic review.

David Chapireau1, David Adlam, Malcolm Cameron, Mark Thompson.   

Abstract

The aim of this study was to review all the paraneoplastic syndromes of primary tumours of the oral cavity. Metastatic tumours of the mouth and primary tumours of the oropharynx (including tonsils), and major salivary glands were excluded. The primary search was conducted on PubMed, Scopus and EMBASE, and included every paraneoplastic syndrome from a primary oral tumour described in English, French, or German papers during the last 20 years. The secondary search was conducted by handpicking articles from reviews on paraneoplastic syndromes of the head and neck. The aim of the tertiary search was to identify conditions that had been reported only rarely. We then cross-referenced "mouth neoplasm" with every paraneoplastic condition cited in relevant review articles. We classified the paraneoplastic syndromes that arose from tumours of the head and neck into six categories: endocrine, dermatological, vascular and haematological, rheumatoid, ocular, and neurological. The following conditions are described in this review: syndrome of inappropriate antidiuretic hormone production, hypercalcaemia, hypercalcaemia-leucocytosis syndrome, ectopic production of beta-human chorionic gonadotrophin, Bazex syndrome, Sweet syndrome, tripe palm syndrome, pemphigus, pityriasis rotunda, neutrophilic leukemoid reaction, cerebral venous sinus thrombophlebitis, digital ischaemia, dermatomyositis, necrotising myopathy, autoimmune retinal degeneration, and subacute cerebellar degeneration. Paraneoplastic syndromes of the oral cavity are a heterogeneous group. Most syndromes occur from squamous cell carcinoma and their aetiology is poorly understood. They are important to recognise as they can be the presenting complaint of a malignant tumour, change the prognosis, and considerably reduce the quality of life. Copyright 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19833419     DOI: 10.1016/j.bjoms.2009.08.025

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  3 in total

1.  Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients.

Authors:  Franziska Peter; Claus Wittekindt; Mira Finkensieper; Michael Kiehntopf; Orlando Guntinas-Lichius
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-25       Impact factor: 4.553

2.  Characteristics of hospitalized dermatomyositis patients with underlying malignancy: a nationally representative retrospective cohort study.

Authors:  Raghav Tripathi; Anthony P Fernandez
Journal:  Arch Dermatol Res       Date:  2020-08-17       Impact factor: 3.017

3.  Bazex syndrome.

Authors:  Ismael Alves Rodrigues; Letícia Trivellato Gresta; Rafaela Carolina Cruz; Giselly Gomes Carvalho; Melissa Heringer Chamon Barros Quintão Moreira
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.